Managing Director at Myeloma Investment Fund (MIF), board member at multiple prestigious institutions, and faculty at MIT. Stephanie brings a wealth of experience from her roles in Pharma (Novartis and Roche), Biotech (Mnemo Therapeutics, Galecto), and Venture (Evotec, RA Capital, MIF). With a Ph.D. in biochemistry and an MPA from Harvard, she combines scientific expertise with strategic insight. Plus, she’s a semi-professional violinist who performs at Carnegie Hall!